Cepravin Dry Cow

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

cephalonium

Available from:

Schering-Plough Animal Health Limited

INN (International Name):

cephalonium

Composition:

cephalonium 83.3 g/kg

Therapeutic area:

Antibiotic

Authorization status:

ACVM Registered

Authorization date:

1977-11-28

Patient Information leaflet

Cepravin Dry Cow
Final Carton text
March 2018
Page 1 of 4
[Front and top flap]
NOTE: Text laid out to match the new global carton box for this
product.
Therefore text only has been provided.
RESTRICTED VETERINARY MEDICINE
Keep out of reach of children
FOR ANIMAL TREATMENT ONLY
CEPRAVIN
®
DRY COW
32 SYRINGES
250mg cephalonium/syringe in a long-acting base
[MSD AH Logo]
Cepravin Dry Cow
Final Carton text
March 2018
Page 2 of 4
[Carton back panel]
READ ENTIRE CARTON BEFORE USE.
INDICATIONS
Routine dry cow therapy is an integral part of mastitis control. In
conjunction with,
proper management of the cow during drying-off and over the dry
period, correct
administration of Cepravin Dry Cow at drying off:

reduces new infections at drying off and in the dry period,

treats subclinical mastitis that may be present at drying off,

and helps reduce SCC’s and mastitis in the subsequent lactation.
ACTION
Cepravin has:

broad-spectrum activity.

an initial high concentration of cephalonium to treat existing
infections;
including those caused by _Staphylococcus aureus_, coagulase negative
Staphylococci (CNS), _Streptococcus uberis, Streptococcus agalactiae,
_
_Streptococcus dysgalactiae, _Corynebacterium and _Escherichia coli_.

effective levels of cephalonium to protect against Staphylococcal and
Streptococcal infections for up to 10 weeks and _E. coli_ infections
for up to 4
weeks.

been shown to be associated with earlier teat closure.
DOSAGE AND ADMINISTRATION
Treatment MUST be at least 49 DAYS BEFORE CALVING. Treat each cow
immediately
following its final milking for the season. Administration must not be
delayed.
When using dry cow preparations, care must be taken not to introduce
infection into
the udder.
Administer one syringe per quarter. Clean the teat thoroughly with a
fresh teat wipe.
Allow to dry. Insert nozzle (either partial or full insertion) and
infuse the full contents
of syringe into the teat canal. Spray carefully with an approved teat
spray.
See detailed infusion procedure on other

Summary of Product characteristics

CEPRAVIN DRY COW
20, 32 and 144 syringes – Leaflet, Tub Labels, Carton and Label
A003322
Page 1 of 17
CEPRAVIN DRY COW
12-Oct-22
Leaflet – 144 syringes
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
CEPRAVIN
® DRY COW
250 MG CEPHALONIUM/SYRINGE IN A LONG-ACTING BASE
READ ENTIRE LEAFLET BEFORE USE.
HANDLING PRECAUTIONS: Contains penicillins which may cause skin
irritation or an allergic
skin reaction. Do not handle this product if you know you are
sensitised, or if you have been
advised not to work with such preparations. Use gloves when handling
this product to avoid
exposure, wash hands after use.
FIRST AID: In case of skin contact, carefully remove any contaminated
clothing and wash skin
thoroughly with soap and water. If irritation or symptoms occur or
persist, consult a doctor. In case
of eye contact, immediately rinse eyes thoroughly with plenty of
water. If irritation occurs or
persists, consult a doctor. For advice contact the National Poisons
Centre 0800 POISON (0800
764 766) or a doctor.
DISPOSAL: Dispose of empty container by puncturing and burying in a
suitable landfill. Where
possible, recycle through AgRecovery. Do NOT burn.
See safety data sheet (SDS) for further information:
www.msd-animal-health.co.nz
INDICATIONS
Routine dry cow therapy is an integral part of mastitis control. In
conjunction with, proper
management of the cow during drying-off and over the dry period,
correct administration of
Cepravin Dry Cow at drying off:
•
reduces new infections at drying off and in the dry period.
•
treats subclinical mastitis that may be present at drying of f.
•
helps to reduce SCC’s and mastitis in the subsequent lactation.
ACTION
Cepravin has:
•
broad-spectrum activity.
•
an initial high concentration of cephalonium to treat existing
infections; including those caused
by _Staphylococcus aureus_, coagulase negative Staphylococci (CNS),
_Streptococcus uberis, _
_Streptococcus agalactiae, Streptococcus dysgalactiae,
_Corynebacterium and _Escherichia co